Alnylam Pharmaceuticals (ALNY) ROA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
ROA, % | ? | -37.0% | -25.2% | -23.4% | -31.9% | -11.5% | -7.90% | ||
Changes by years, y/y, % | +11pp | +12pp | +2pp | -8pp | +20pp | -25.0% |
Alnylam Pharmaceuticals. ROA, %
Alnylam Pharmaceuticals. ROA, changes, pp
Alnylam Pharmaceuticals (ALNY) ROA US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
ROA, % | ? | -13.3% | -11.5% | -8.68% | -1.82% | -7.90% | -7.90% | |
Changes by years, y/y, % | +20pp | +20pp | +23pp | +29pp | +5pp | |||
Changes by quarters, q/q, % | +18pp | +2pp | +3pp | +7pp | -6pp |